Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, ... Read more
Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ... Read more
The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more
Consuming frying oil may worsen colon inflammation and colon cancer, a study in mice suggests. The study, “Thermally processed oil exaggerates colonic inflammation and colitis-associated colon tumorigenesis in mice,” ... Read more
A survey of gastroenterologists in the United States shows that data from the VARSITY clinical trial, as well as safety concerns about the experimental treatment Xeljanz, are affecting how ... Read more
The pharmaceutical company Eli Lilly has announced an open innovation challenge for individuals, teams, and organizations in the United States to propose digital health solutions that can improve care ... Read more
The Israel-based company Stero Biotechs announced it soon will conduct a study to test a cannabidiol (CBD)-based solution as a potential treatment for steroid-dependent Crohn’s disease (SDCD). SDCD is ... Read more